Page last updated: 2024-09-03

sch 23982 and Angioblastic Meningioma

sch 23982 has been researched along with Angioblastic Meningioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fahlbusch, R; Nomikos, P; Schrell, UM1
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM1

Other Studies

2 other study(ies) available for sch 23982 and Angioblastic Meningioma

ArticleYear
Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue.
    Journal of neurosurgery, 1992, Volume: 77, Issue:2

    Topics: Adult; Aged; Benzazepines; Female; Guanylyl Imidodiphosphate; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1992
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 71, Issue:6

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured

1990